Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nazanin Karimnia

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|March 27, 2019
Therapeutic Targeting of Collective Invasion in Ovarian CancerLaura Moffitt, Nazanin Karimnia, Andrew Stephens, et al.
Experimental Hematology|October 1, 2023
Metabolic regulation of aged hematopoietic stem cells: key players and mechanismsNazanin Karimnia, James Harris, Shen Y Heazlewood, et al.
Current Oncology (Toronto, Ont.)|December 27, 2024
Challenges in Implementing Comprehensive Precision Medicine Screening for Ovarian CancerLaura R Moffitt, Nazanin Karimnia, Amy L Wilson, et al.
Non-Coding RNA|April 17, 2018
Current perspectives in Set7 mediated stem cell differentiationNazanin Karimnia, Haloom Rafehi, Natasha K Tuano, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 2, 2021
Chemoresistance is mediated by ovarian cancer leader cells in vitroNazanin Karimnia, Amy L Wilson, Emma Green, et al.
Advanced Healthcare Materials|March 20, 2025
A Novel 3D High-Throughput Phenotypic Drug Screening Pipeline to Identify Drugs with Repurposing Potential for the Treatment of Ovarian CancerNazanin Karimnia, Amy L Wilson, Brittany R Doran, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|March 27, 2019
Therapeutic Targeting of Collective Invasion in Ovarian CancerLaura Moffitt, Nazanin Karimnia, Andrew Stephens, et al.
Experimental Hematology|October 1, 2023
Metabolic regulation of aged hematopoietic stem cells: key players and mechanismsNazanin Karimnia, James Harris, Shen Y Heazlewood, et al.
Current Oncology (Toronto, Ont.)|December 27, 2024
Challenges in Implementing Comprehensive Precision Medicine Screening for Ovarian CancerLaura R Moffitt, Nazanin Karimnia, Amy L Wilson, et al.
Non-Coding RNA|April 17, 2018
Current perspectives in Set7 mediated stem cell differentiationNazanin Karimnia, Haloom Rafehi, Natasha K Tuano, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 2, 2021
Chemoresistance is mediated by ovarian cancer leader cells in vitroNazanin Karimnia, Amy L Wilson, Emma Green, et al.
Advanced Healthcare Materials|March 20, 2025
A Novel 3D High-Throughput Phenotypic Drug Screening Pipeline to Identify Drugs with Repurposing Potential for the Treatment of Ovarian CancerNazanin Karimnia, Amy L Wilson, Brittany R Doran, et al.
Pageof 1